Want to see NVST full AI Analyst Report?
NVST Stock Chart & Stats
$27.84
-$0.72(-3.69%)
At close: 4:00 PM EST
$27.84
-$0.72(-3.69%)
Day’s Range― - ―
52-Week Range$18.77 - $30.42
Previous CloseN/A
Volume757.64K
Average Volume (3M)2.60M
Market Cap
$4.33B
Enterprise Value$4.80K
Total Cash (Recent Filing)$1.08B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)63.3
Beta1.01
Next Earnings
Aug 05, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.42
Shares Outstanding162,727,920
10 Day Avg. Volume2,740,682
30 Day Avg. Volume2,602,454
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$29.00Price Target Upside4.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.43
Revenue Forecast (FY)$2.86B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationRobust trailing‑twelve‑month free cash flow provides durable internal funding for capex, tuck‑in M&A and capital returns (buybacks). Reliable cash conversion reduces refinancing dependence, supports reinvestment and gives management flexibility across a 2–6 month horizon and beyond.
High And Expanding MarginsConsistently strong gross margins and recent margin expansion reflect pricing power and a favourable product mix (consumables, equipment). Margin resilience helps absorb tariff and input pressure, sustain profitability and fund R&D/product rollout over the medium term.
Diversified Portfolio And Product InnovationBroad exposure across implants, orthodontics, consumables and imaging plus visible new‑product traction and targeted tuck‑in M&A (e.g., Versah) diversify revenue sources, improve cross‑sell and raise structural growth potential, supporting steadier medium‑term top‑line performance.
Bears Say
Thin, Volatile ProfitabilityNet margins remain thin and earnings have swung from losses to modest profit, which limits the company's ability to absorb demand shocks or fund growth internally. Persistent volatility reduces confidence in sustained profitability even if recent trends are improving.
China Implants VBP And Channel Destocking RiskRegulatory procurement shifts (VBP) and preemptive channel destocking in China create structural uncertainty in a sizable market. Timing and scope remain unclear; prolonged VBP effects can compress volumes and margins and require sustained investment to rebuild channel flows.
Meaningful Debt And Low ROEMaterial net debt and low return on equity indicate capital is not yet earning strong returns. Leverage reduces strategic flexibility for larger acquisitions or weathering setbacks if growth stalls, and low ROE suggests capital allocation must improve to sustain long‑term value creation.
Envista Holdings News
NVST FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was $18.77 and its highest was $30.42 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is $4.33B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is Aug 05, 2026 which is in 14 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on May 06, 2026. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.312 by $0.048.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Undervalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 0.34.
How many shares outstanding does Envista Holdings Corp have?
Envista Holdings Corp has 162,727,920 shares outstanding.
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of $0.36 in its last earnings report, beating expectations of $0.312. Following the earnings report the stock price went down -10.27%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$29.00 (4.17% Upside)
$29.00 (4.17% Upside)
Blogger Sentiment
Bullish
NVST Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.04%
Trailing 12-Months
Company Description
Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$29.00
▲(4.17% Upside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
0.74% Insiders
37.62% Mutual Funds
0.23% Other Institutional Investors
36.46% Public Companies and
Individual Investors